{
  "document_id": "5bd3d363a2aafefb00eac22c48baa5734693881ee684813829e465a8577cdb07",
  "crypto_record": {
    "document_id": "5bd3d363a2aafefb00eac22c48baa5734693881ee684813829e465a8577cdb07",
    "content_hash": "5bd3d363a2aafefb00eac22c48baa5734693881ee684813829e465a8577cdb07",
    "collection_timestamp": "2025-07-09T20:27:16.724728",
    "source_metadata": {
      "title": "FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say",
      "url": "https://www.propublica.org/article/fda-cuts-drug-factory-inspections",
      "source": "ProPublica",
      "bias_label": "center-left",
      "published": "2025-07-07",
      "collected_at": "2025-07-09T20:26:58.649727",
      "id": "9b8460785c82_1752092836723",
      "author": "Victoria Malis; Katherine Dailey; Sadie Leite; Debbie Cenziper; Megan Rose",
      "via_google_news": false,
      "via_gdelt": false,
      "via_gov_api": false,
      "extraction_method": "trafilatura",
      "document_id": "9b8460785c82_1752092836723",
      "stored_at": "2025-07-09T20:27:16.724042"
    },
    "collector_version": "1.0.0",
    "collection_method": "unknown",
    "original_url": "https://www.propublica.org/article/fda-cuts-drug-factory-inspections",
    "stored_doc_id": "9b8460785c82_1752092836723"
  },
  "collection_signature": "NR21kyOxrBL6YZQJRbBp9+BdSHhlwgYEWt6bW5Cv6t8=",
  "lineage_type": "document_collection",
  "created_at": "2025-07-09T20:27:16.724803"
}